MS Pharma is a multinational pharmaceutical company headquartered in Amman – Jordan that manufactures and markets innovative products across Middle East, Africa and Europe. The company leverages 9 manufacturing sites in Algeria, Jordan, Turkey, KSA and Greece to sell its products in over 60 countries worldwide, with a capacity of 600 million boxes per year. We have the ability to manufacture different dosage forms from solid (including soft gelatin capsule), liquid, semi-solids, oral oncology, multipurpose injectables, and oncology injectables. MS Pharma has a diversified team of 2,700 ambitious and highly skilled employees, which helped to achieve more than 2,000 registered products and 365 products in the pipeline. We cover a wide range of therapeutic classes in the chronic and acute diseases from Cardiovascular and Diabetes, Central Nervous System, Oncology, Autoimmune Diseases, Hematology, Musculoskeletal, Respiratory, Alimentary, Systemic Antibiotics to Dermatology, beside a wide range of cosmeceutical and consumer products. Recently MS Pharma acquired Genepharm – a multinational pharmaceutical company that is based in Greece and focuses on chronic diseases like Cardiovascular, CNS and Oncology.